Sandbox:Roukoz: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 11: | Line 11: | ||
{{familytree | | |!| | | | | | | | | | | | |!| | }} | {{familytree | | |!| | | | | | | | | | | | |!| | }} | ||
{{familytree |,|-|+|-|.| | | | | | | | |,|-|^|-|.| }} | {{familytree |,|-|+|-|.| | | | | | | | |,|-|^|-|.| }} | ||
{{familytree |F01 | {{familytree |F01|F02| |F03| | | | | | |F04| | |F05| |F01=bone|F02=Ing|F03=Supra}} | ||
{{familytree/end}} | {{familytree/end}} | ||
Revision as of 19:18, 10 October 2018
| Tumor of unknown primary origin | |||||||||||||||||||||||||||||||||||||||||||||||||
| • Full medical history and physical exam • Basic blood and bichemical analysis • CT scan of chest, abdomen, and pelvis | |||||||||||||||||||||||||||||||||||||||||||||||||
| Histopathologic examination | |||||||||||||||||||||||||||||||||||||||||||||||||
| Squamous cell carcinoma | Neuroendocrine carcinoma | Adenocarcinoma and poorly differntiated carcinoma | |||||||||||||||||||||||||||||||||||||||||||||||
| Additional tests specific to location of metastasis | • Octreoscan • Plasma chromogranin A | Gender specific tests | |||||||||||||||||||||||||||||||||||||||||||||||
| bone | Ing | Supra | {{{F04}}} | {{{F05}}} | |||||||||||||||||||||||||||||||||||||||||||||